AMY ALEXANDER: Open Payments
NPI 1295083517 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 24 payments from 12 companies in 2025. Trend: 2023 $678 · 2024 $1,135 · 2025 $806
Food & beverage: $769Education: $37
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 6 | $317 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| Fresenius USA Marketing, Inc. | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Aurinia Pharma U.S., Inc. | 2 | $42 |
| OPKO Pharmaceuticals, LLC | 2 | $37 |
| Travere Therapeutics, Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: XPHOZAH 30 MG, Kerendia, VELPHORO, IBSRELA, JYNARQUE, LUPKYNIS, RAYALDEE, Vanrafia.
Industry payments across KY — which companies pay providers there.
